Healthcare news, data and analysis
Via Investors in Healthcare
Sweden: Asker bolts Dartin onto Aspironix
Asker Healthcare Group has signed an agreement to acquire 100% of the shares in Dartin, a niche distributor of medical equipment in the Czech Republic and Slovakia. Dartin specialises in […]
Asker Healthcare Group has signed an agreement to acquire 100% of the shares in Dartin, a niche distributor of medical equipment in the Czech Republic and Slovakia. Dartin specialises in […]
Sweden: Asker bolts Dartin onto Aspironix
July 18, 2025
Life Sciences
M&A
Medtech – Hospital Equipment
Medtech – Medical Devices and Implants
News
Italy: KKR said mulling takeover of GPI Group
News reports point to KKR planning a takeover of GPI Group, an Italy-listed developer of software solutions, services, and technologies to support the digital transformation and sustainability of healthcare systems. […]
News reports point to KKR planning a takeover of GPI Group, an Italy-listed developer of software solutions, services, and technologies to support the digital transformation and sustainability of healthcare systems. […]
Italy: KKR said mulling takeover of GPI Group
July 18, 2025
Digital Health/Healthtech
Healthcare
News
GPI Group
Italy
Germany: Embla Medical takes majority stake in Streifeneder ortho.production
Iceland-headquartered Embla Medical (formerly Ossur), a Nasdaq Copenhagen listed provider of mobility solutions, has signed an agreement to invest in a majority share (51% of the shares) in privately owned Streifeneder […]
Iceland-headquartered Embla Medical (formerly Ossur), a Nasdaq Copenhagen listed provider of mobility solutions, has signed an agreement to invest in a majority share (51% of the shares) in privately owned Streifeneder […]
Germany: Embla Medical takes majority stake in Streifeneder ortho.production
July 18, 2025
Life Sciences
M&A
Medtech – Medical Devices and Implants
News
Embla Medical (Ossur)
Switzerland: Novartis appoints Mukul Mehta as CFO
Novartis has announced the appointment of Mukul Mehta as CFO and a member of the executive committee, effective 16 March 2026. He succeeds Harry Kirsch, who has served as CFO […]
Novartis has announced the appointment of Mukul Mehta as CFO and a member of the executive committee, effective 16 March 2026. He succeeds Harry Kirsch, who has served as CFO […]
Switzerland: Novartis appoints Mukul Mehta as CFO
July 17, 2025
People
Pharma
Harry Kirsch
Mukul Mehta
Novartis
US: Walgreens Boots Alliance shareholders approve bid from Sycamore
Shareholders in Nasdaq-listed Walgreens Boots Alliance (WBA) have approved the takeover bid from US investors Sycamore Partners Management, a private equity firm specializing in retail, consumer and distribution-related investments. Under […]
Shareholders in Nasdaq-listed Walgreens Boots Alliance (WBA) have approved the takeover bid from US investors Sycamore Partners Management, a private equity firm specializing in retail, consumer and distribution-related investments. Under […]
US: Walgreens Boots Alliance shareholders approve bid from Sycamore
July 17, 2025
Buy Out
Healthcare
M&A
News
Pharmacy
UK: Charity appoints three new trustees to board
Royal Brompton & Harefield Hospitals Charity has appointed Matthew Kennedy, Charlie Carrington-Brown, and Gira Davda to its board of trustees. The new trustees bring a wealth of experience and passion that […]
Royal Brompton & Harefield Hospitals Charity has appointed Matthew Kennedy, Charlie Carrington-Brown, and Gira Davda to its board of trustees. The new trustees bring a wealth of experience and passion that […]
UK: Charity appoints three new trustees to board
July 17, 2025
Healthcare
Hospitals and Clinics
News
People
Charlie Carrington-Brown
Switzerland-based Medartis, one of the world’s leading manufacturers and providers of medical devices for surgical fixation of bone fractures, has decided to acquire the remaining 53% of KeriMedical, a Switzerland-based […]
UK: Circle Health Group appoints Paul Manning as CEO
Circle Health Group, the UK’s largest private hospital operator, a subsidiary of PureHealth, has announced the appointment of Paul Manning as its new CEO. Karen Prins, former Chief Operating Officer and […]
Circle Health Group, the UK’s largest private hospital operator, a subsidiary of PureHealth, has announced the appointment of Paul Manning as its new CEO. Karen Prins, former Chief Operating Officer and […]
UK: Circle Health Group appoints Paul Manning as CEO
July 17, 2025
Healthcare
Hospitals and Clinics
News
Circle Health Group
Karen Prins
France: Eurazeo announces first close of Growth Fund IV
Euronext Paris-listed PE firm Eurazeo has announced the first close of Eurazeo Growth Fund IV (EGF IV) at €650m (US$753m) with prominent European institutions among its initial investors. Christophe Bavière […]
Euronext Paris-listed PE firm Eurazeo has announced the first close of Eurazeo Growth Fund IV (EGF IV) at €650m (US$753m) with prominent European institutions among its initial investors. Christophe Bavière […]
France: Eurazeo announces first close of Growth Fund IV
July 17, 2025
Digital Health/Healthtech
Healthcare
Life Sciences
Medtech – Healthcare IT
News
UK: THI Investments backs Empowering Learning Group
Germany-based THI Investments, a privately-owned pan European private equity investor, has acquired a majority stake in Empowering Learning Group (ELG)—the UK’s leading provider of specialist behaviour-management training and teacher recruitment […]
Germany-based THI Investments, a privately-owned pan European private equity investor, has acquired a majority stake in Empowering Learning Group (ELG)—the UK’s leading provider of specialist behaviour-management training and teacher recruitment […]
UK: THI Investments backs Empowering Learning Group
July 16, 2025
Buy Out
Education
M&A
News
SEN Schools
Spain: Apheon partners with Longwood for future growth
Apheon, a pan-European mid-market private equity investor primarily investing in companies in Benelux, France, Germany, Italy and Spain, has acquired a majority stake in Longwood, a Spanish distributor and provider […]
Apheon, a pan-European mid-market private equity investor primarily investing in companies in Benelux, France, Germany, Italy and Spain, has acquired a majority stake in Longwood, a Spanish distributor and provider […]
Spain: Apheon partners with Longwood for future growth
July 16, 2025
Buy Out
Diagnostics
Healthcare
IVD – Tools
Life Sciences
Singapore: Safe Life enters Asia with HTM Medico acquisition
Safe Life, a provider of life-saving solutions with operations across Europe and North America, has announced its latest acquisition since Bridgepoint took a controlling stake in Stockholm-based company in June. This time, expanding […]
Safe Life, a provider of life-saving solutions with operations across Europe and North America, has announced its latest acquisition since Bridgepoint took a controlling stake in Stockholm-based company in June. This time, expanding […]
Singapore: Safe Life enters Asia with HTM Medico acquisition
July 16, 2025
Buy Out
Life Sciences
M&A
Medtech – Medical Devices and Implants
News
UK: Bourne Partners announces European expansion with James West appointment
US-based Bourne Partners, a full-service Healthcare-focused investment banking firm, is expanding its operation in Europe with the addition of James West as managing director. The appointment of West and additional […]
US-based Bourne Partners, a full-service Healthcare-focused investment banking firm, is expanding its operation in Europe with the addition of James West as managing director. The appointment of West and additional […]
UK: Bourne Partners announces European expansion with James West appointment
July 15, 2025
People
Pharma
Services – CRO/CMO/CDMO
Banks Bourne
Bourne Partners
UK: UKAT expands footprint on South Coast with addition of Providence
Sullivan Street Partners portfolio company, UK Addiction Treatment Group (UKAT) – the UK’s leading provider of private residential addiction services – has completed the add-on acquisition of The Providence Projects […]
Sullivan Street Partners portfolio company, UK Addiction Treatment Group (UKAT) – the UK’s leading provider of private residential addiction services – has completed the add-on acquisition of The Providence Projects […]
UK: UKAT expands footprint on South Coast with addition of Providence
July 15, 2025
Buy Out
Healthcare
Hospitals and Clinics
M&A
News
France: Extens strengthens team with three hires and internal promotion
Extens, the France-based dedicated European software investor for healthcare, has expanded its team with the addition of three new professionals and announced one internal promotion. The investment team sees the […]
Extens, the France-based dedicated European software investor for healthcare, has expanded its team with the addition of three new professionals and announced one internal promotion. The investment team sees the […]
France: Extens strengthens team with three hires and internal promotion
July 15, 2025
Digital Health/Healthtech
Healthcare
People
Antoine Pringiers
Extens
Ireland: Perrigo plans divestment of dermacosmetics business to KKR
Dublin-headquartered Perrigo, a New York-listed provider of consumer self-care products, is selling its dermacosmetics branded business for up to €327m (US$382m) to KKR. The transaction includes €300m in upfront cash and […]
Dublin-headquartered Perrigo, a New York-listed provider of consumer self-care products, is selling its dermacosmetics branded business for up to €327m (US$382m) to KKR. The transaction includes €300m in upfront cash and […]
Ireland: Perrigo plans divestment of dermacosmetics business to KKR
July 15, 2025
Buy Out
Cosmetic & Aesthetics
Healthcare
M&A
News
US: PCI enters next phase of growth with strategic investment from Bain Capital, Kohlberg, and Mubadala
US-headquartered PCI Pharma Services (PCI), a global CDMO focused on innovative biotherapies, has received a strategic investment co-led by Bain Capital and existing lead investor Kohlberg, and supported with significant reinvestment by Mubadala. […]
US-headquartered PCI Pharma Services (PCI), a global CDMO focused on innovative biotherapies, has received a strategic investment co-led by Bain Capital and existing lead investor Kohlberg, and supported with significant reinvestment by Mubadala. […]
US: PCI enters next phase of growth with strategic investment from Bain Capital, Kohlberg, and Mubadala
July 15, 2025
Buy Out
M&A
News
Pharma
Services – CRO/CMO/CDMO
UK: LDC deepens healthcare experience with appointment of Amit Thaper
LDC, a UK-based private equity investor and part of Lloyds Banking Group, has increased its support for healthcare businesses with the appointment of Amit Thaper as investment director working alongside […]
LDC, a UK-based private equity investor and part of Lloyds Banking Group, has increased its support for healthcare businesses with the appointment of Amit Thaper as investment director working alongside […]
UK: LDC deepens healthcare experience with appointment of Amit Thaper
July 14, 2025
Healthcare
Life Sciences
People
Pharma
Amit Thaper
UK: Elevation announces first close of third credit fund and completes inaugural transaction
Elevation Advisors, a UK-based specialist investment manager in the healthcare real estate sector, has completed the first closing for Elevation Credit Partners III (ECP III) – Elevation’s third private credit […]
Elevation Advisors, a UK-based specialist investment manager in the healthcare real estate sector, has completed the first closing for Elevation Credit Partners III (ECP III) – Elevation’s third private credit […]
UK: Elevation announces first close of third credit fund and completes inaugural transaction
July 14, 2025
Care Homes
Debt
News
Social Care
Elevation Advisors
Switzerland: Nuclidium closes CHF79m Series B to advance clinical development of copper-based radiopharmaceutical platform
Nuclidium, a Switzerland-based clinical-stage radiopharmaceutical company developing a proprietary copper-based theranostic platform, has closed its Series B financing round, raising CHF79m (US$99m). The round was led by Kurma Growth Opportunities […]
Nuclidium, a Switzerland-based clinical-stage radiopharmaceutical company developing a proprietary copper-based theranostic platform, has closed its Series B financing round, raising CHF79m (US$99m). The round was led by Kurma Growth Opportunities […]
Switzerland: Nuclidium closes CHF79m Series B to advance clinical development of copper-based radiopharmaceutical platform
July 14, 2025
Life Sciences
Medtech – Hospital Equipment
News
Venture
Angelini Ventures
Ireland: Renee Gala elected CEO at Jazz Pharma
Dublin-headquartered Jazz Pharmaceuticals, a Nasdaq-listed global biopharma company, has elected Renee Gala as president and CEO, effective 11 August. She succeeds co-founder, chairperson and CEO Bruce Cozadd, who informed the board in December […]
Dublin-headquartered Jazz Pharmaceuticals, a Nasdaq-listed global biopharma company, has elected Renee Gala as president and CEO, effective 11 August. She succeeds co-founder, chairperson and CEO Bruce Cozadd, who informed the board in December […]
Ireland: Renee Gala elected CEO at Jazz Pharma
July 14, 2025
People
Pharma
Bruce Cozadd
Ireland
Jazz Pharmaceuticals
UK: EuroAPI sells Haverhill site to Particle Dynamics as part of its Focus-27 transformation plan
Euronext-listed EuroAPI, a France-based player in active pharmaceutical ingredients has signed a share purchase agreement (SPA) for the sale of 100% of EuroAPI UK, the subsidiary operating its Haverhill manufacturing […]
Euronext-listed EuroAPI, a France-based player in active pharmaceutical ingredients has signed a share purchase agreement (SPA) for the sale of 100% of EuroAPI UK, the subsidiary operating its Haverhill manufacturing […]
UK: EuroAPI sells Haverhill site to Particle Dynamics as part of its Focus-27 transformation plan
July 14, 2025
M&A
M&A Deals
News
Pharma
Real Estate
Egypt: DPI makes largest healthcare investment of its kind in Egypt
Africa focused, multi-strategy private investment firm, Development Partners International (DPI), and co-investors, are taking a US$190m minority stake in Alameda Healthcare, Egypt’s leading private healthcare group, to accelerate Alameda’s expansion […]
Africa focused, multi-strategy private investment firm, Development Partners International (DPI), and co-investors, are taking a US$190m minority stake in Alameda Healthcare, Egypt’s leading private healthcare group, to accelerate Alameda’s expansion […]
Egypt: DPI makes largest healthcare investment of its kind in Egypt
July 14, 2025
Clinical Labs
Healthcare
Hospitals and Clinics
News
Venture
CDMOs: the changing shape of outsourcing
The contract development and manufacturing organization (CDMO) sector is undergoing structural evolution, driven by increased outsourcing, rising complexity, cost pressures and a shift in customer expectations across pharma and medtech. […]
The contract development and manufacturing organization (CDMO) sector is undergoing structural evolution, driven by increased outsourcing, rising complexity, cost pressures and a shift in customer expectations across pharma and medtech. […]
CDMOs: the changing shape of outsourcing
July 11, 2025
Analysis
Life Sciences
Medtech – Medical Devices and Implants
News
Pharma
France: Argos Vétérinaire secures €100m in unitranche financing from Adams Street
G-Square Healthcare portfolio company, Argos Vétérinaire, a group of independent veterinary clinics across 110 locations in France, has closed a new round of over €100m (US$117m) in unitranche financing with […]
G-Square Healthcare portfolio company, Argos Vétérinaire, a group of independent veterinary clinics across 110 locations in France, has closed a new round of over €100m (US$117m) in unitranche financing with […]
France: Argos Vétérinaire secures €100m in unitranche financing from Adams Street
July 11, 2025
Debt
News
Veterinary
Veterinary Clinics
Adams Street Partners
Our Sectors
We are experts at what we do
01
Our People
A dedicated team of executive search experts, delivering for you
The Compass Carter Osborne team are healthcare and life science experts. As a trusted advisor we bring decades of search experience and an unparalleled track record of delivery across our dedicated sectors for our investor clients – relied upon time and again to build outstanding leadership teams.
Familiar faces at key industry events, our expertise extends beyond the mere placing of people with our consultants bringing together sector leaders to address key challenges, working in partnership to produce tangible solutions.
02
Expertise
Unearthing rare talent, that drive successful exits
Responsive, adaptable, and emotionally intelligent, Compass Carter Osborne avoid the one-size-fits-all approach to ensure our clients achieve their desired outcome by presenting a broad range of intuitive, tailored solutions, based on specific needs.
03
Our Approach
Tailoring our offering,
to provide a bespoke service
Results driven, not process led, CCO avoid the conformity of a rigid process. Never assumptive, we listen and adopt an agreed approach which most closely delivers to a clients specific needs. Understanding the uniqueness of each role, our people tailor a search to bespoke requirements to ensure solutions that delivers the best possible results first time, every time.
A trusted advisor to the investment community
providing leaders advancing the healthcare and life sciences sectors
What our clients say
“Compass Carter Osborne really delivered for us in our search for a new CEO for Outcomes First Group. It was a vitally important assignment given that we were recruiting a successor for a long standing and highly successful CEO in a sector-leading business. Compass Carter Osborne went above and beyond in developing a deep understanding of the business and our requirements, and in only presenting candidates that closely met these. They think very creatively and their focus was very sharp; they particularly understood the culture of the business. The search was speedy and well organised, with a very high standard of verbal and written feedback. They have a granular knowledge of the sector and because of the way in which they work, we were fully involved throughout and achieved a great result. A really excellent search – thank you.”
Outcomes First Group – Chair
“Compass Carter Osborne started from the very beginning with a detailed, professional explanation of the available position. They spent time to present the great opportunity and chance to accelerate my career but at the same time, the challenge, and the strong expectation from their client.”
Hengrui Therapeutics – VP, Head Biological Drug Discovery
“Compass Carter Osborne delivered on a key appointment for the PFA and the wider football industry. It was a complex brief involving creating an entirely new position. The role was vitally important, with the successful candidate taking on a sensitive and multifaceted responsibility across CTE, concussion and brain health in professional football. CCO led a comprehensive and exhaustive process, developing a deep understanding of the union’s requirements and using his expert knowledge to help scope and evolve the brief throughout the search. The entire process was professional, efficient and well organised, with consistent communication and feedback at every stage.”
The Professional Footballers Association (PFA) – Chief Executive Officer
“I have been so impressed by Luke’s integrity, clear purpose and drive to achieve for his clients. Luke has worked with Priory on a number of things but more recently to source two independent Non Executive Directors and a Director of Talent Acquisition. He has kept us informed, fielded some great candidates and follows up at each stage, even when they have started. I would really recommend him if you are searching for high calibre individuals.”
Priory Group – Chief Executive Officer
“I recently had the pleasure of being appointed to an independent healthcare provider as a NED after being put forward for the role by Luke. Throughout the whole recruitment process I was treated with respect and felt valued. I was particularly impressed with the follow up support after the decision to appoint me, which I have never experienced from other search companies. Luke continued to check in with me to ensure my onboarding went smoothly and that I had settled into the role. Overall, a highly professional and comprehensive approach delivered personally by Luke.”
Priory – Independent Non-Executive Director
“Luke was absolutely brilliant along the journey. He acted as a real partner and was able to answer to all my questions in order to get comfortable with the decision of making the change. His expertise and knowledge of the sector really came out along the process. Most importantly, he was always available when I needed him to be, which is something I valued a lot. In summary, I couldn’t recommend him and Compass Carter Osborne enough.”
AniCura – Group Chief Operating Officer
“We worked with Compass Carter Osborne in the search for our Chief Financial Officer and from the start it was clear they were a good choice of partner. A focus on understanding our needs as a business, and mine personally as a CEO were front of mind for Paul and Kieran. They took the time to listen, understand and not only focus on the functional aspects of the role – but critically, the team fit and culture we are building.
Process, structure and follow-through were like clockwork, and the quality of candidates were of a consistently high-level. I would highly recommend Compass Carter Osborne.”
Renaiss Health – Chief Executive Officer
“I’ve known Tarquin for over 15 years, during which time he has delivered a number of executive assignments at senior level, including COO/executive team and senior management roles in scientific/professional disciplines (his network in the biotech/life-sciences sector is second-to-none!). He works hard to truly understand both the candidate brief and the culture of the company, sets realistic expectations and retains regular contact as an assignment progresses, always providing thorough updates and pragmatic advice. He has the highest levels of professionalism and integrity – he really is a pleasure to work with.”
One Nucleus – Director
“Jamie did a great job – he really took the time to understand our business, our needs and what we were looking for. We knew our brief was specific, yet Jamie met all our expectations with the search. He maintained a high standard of communication and meticulous attention to detail throughout the process. I would recommend Jamie and the Compass Carter Osborne team without hesitation.”
Melrose Education – Chair & CEO
“Our recent work with Compass Carter Osborne was exceptional. The search was perfectly organised, response times were swift, and due to the consultant market knowledge and network, we quickly found our ideal candidate.”
Schoen Clinic – Member of Group Executive
The latest insights from
Compass Carter Osborne
Attracting US investors: what UK life science companies need to know
Attracting US investors: what UK life science companies need to know
June 10, 2025
Insight
Life Science
